Inogen, Inc. (INGN)

Market Cap	524.66M
Revenue (ttm)	365.55M
Net Income (ttm)	-50.04M
Shares Out	22.88M
EPS (ttm)	-0.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	222,750
Open	22.41
Previous Close	22.89
Day's Range	22.08 - 23.16
52-Week Range	19.48 - 36.3
Beta	0.96
Analysts	Buy
Price Target	27.88 (+21.2%)
Earnings Date	Nov 2, 2022

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat...

• Industry: Health Care Equipment & Supplies
• IPO Date: Feb 14, 2014
• CEO: Scott Wilkinson
• Employees: 1,021
• Stock Exchange: NASDAQ
• Ticker Symbol: INGN

Full Company Profile

Financial Performance

In 2021, Inogen's revenue was $358.00 million, an increase of 16.05% compared to the previous year's $308.49 million. Losses were -$6.33 million, 8.65% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for INGN stock is "Buy." The 12-month stock price forecast is 27.88, which is an increase of 21.22% from the latest price.

Price Target

$27.88

(21.22% upside)

Analyst Consensus: Buy

Stock Forecasts